An open-label study to evaluate the potential pharmacokinetic interaction between PLA-695 [giripladib] and methotrexate when coadministered orally to adult subjects with rheumatoid arthritis
Phase of Trial: Phase I
Latest Information Update: 11 Dec 2007
At a glance
- Drugs Giripladib (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Wyeth
- 11 Dec 2007 Status changed from recruiting to completed.
- 22 Oct 2007 New trial centres added.
- 04 Apr 2007 New trial record.